DK154503C - Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf - Google Patents
Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte derafInfo
- Publication number
- DK154503C DK154503C DK193580A DK193580A DK154503C DK 154503 C DK154503 C DK 154503C DK 193580 A DK193580 A DK 193580A DK 193580 A DK193580 A DK 193580A DK 154503 C DK154503 C DK 154503C
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- hydroxybenzoeoic
- benzodioxan
- ylmethyl
- dihydro
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 3
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3624379 | 1979-05-04 | ||
| US06/036,243 US4206125A (en) | 1979-05-04 | 1979-05-04 | 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK193580A DK193580A (da) | 1980-11-05 |
| DK154503B DK154503B (da) | 1988-11-21 |
| DK154503C true DK154503C (da) | 1989-04-10 |
Family
ID=21887496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK193580A DK154503C (da) | 1979-05-04 | 1980-05-01 | Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4206125A (en:Method) |
| JP (1) | JPS55147274A (en:Method) |
| AT (1) | AT369365B (en:Method) |
| AU (1) | AU531739B2 (en:Method) |
| BE (1) | BE883087A (en:Method) |
| CA (1) | CA1148963A (en:Method) |
| CH (1) | CH645372A5 (en:Method) |
| DE (1) | DE3014738A1 (en:Method) |
| DK (1) | DK154503C (en:Method) |
| ES (1) | ES8104997A1 (en:Method) |
| FR (1) | FR2455598A1 (en:Method) |
| GB (1) | GB2051780B (en:Method) |
| IE (1) | IE49564B1 (en:Method) |
| IL (1) | IL59681A (en:Method) |
| IT (1) | IT1127441B (en:Method) |
| NL (1) | NL8002208A (en:Method) |
| NO (1) | NO153572C (en:Method) |
| NZ (1) | NZ193236A (en:Method) |
| PH (1) | PH15963A (en:Method) |
| SE (1) | SE434745B (en:Method) |
| ZA (1) | ZA801603B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI892036A7 (fi) * | 1986-10-31 | 1989-04-28 | Pfizer | Suhteellisen pienen molekyylipainon omaavia polypeptidejä reniininestä jinä |
| JP2931986B2 (ja) * | 1989-02-17 | 1999-08-09 | 武田薬品工業株式会社 | アラルキルアミン誘導体 |
| ATE369353T1 (de) * | 2002-10-22 | 2007-08-15 | Glaxo Group Ltd | Medizinisch verwendbare arylethanolamin verbindungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054104A (en:Method) * | 1962-07-20 | |||
| US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
| US3883560A (en) * | 1973-07-05 | 1975-05-13 | Colgate Palmolive Co | Salicylamidophenethanolamines |
| CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
| JPS55124742A (en) * | 1979-03-20 | 1980-09-26 | Kyowa Hakko Kogyo Co Ltd | Novel aminoalcohol derivative |
-
1979
- 1979-05-04 US US06/036,243 patent/US4206125A/en not_active Expired - Lifetime
-
1980
- 1980-03-19 ZA ZA00801603A patent/ZA801603B/xx unknown
- 1980-03-20 IE IE572/80A patent/IE49564B1/en not_active IP Right Cessation
- 1980-03-21 IL IL59681A patent/IL59681A/xx unknown
- 1980-03-24 NZ NZ193236A patent/NZ193236A/xx unknown
- 1980-03-28 PH PH23837A patent/PH15963A/en unknown
- 1980-04-02 AU AU57077/80A patent/AU531739B2/en not_active Expired
- 1980-04-09 IT IT48373/80A patent/IT1127441B/it active
- 1980-04-16 NL NL8002208A patent/NL8002208A/nl not_active Application Discontinuation
- 1980-04-17 CA CA000350104A patent/CA1148963A/en not_active Expired
- 1980-04-17 DE DE19803014738 patent/DE3014738A1/de active Granted
- 1980-04-18 JP JP5054980A patent/JPS55147274A/ja active Granted
- 1980-04-22 CH CH309380A patent/CH645372A5/de not_active IP Right Cessation
- 1980-04-23 ES ES490814A patent/ES8104997A1/es not_active Expired
- 1980-04-25 GB GB8013770A patent/GB2051780B/en not_active Expired
- 1980-04-29 SE SE8003243A patent/SE434745B/sv not_active IP Right Cessation
- 1980-04-30 AT AT0232780A patent/AT369365B/de not_active IP Right Cessation
- 1980-04-30 FR FR8009849A patent/FR2455598A1/fr active Granted
- 1980-05-01 DK DK193580A patent/DK154503C/da not_active IP Right Cessation
- 1980-05-02 BE BE0/200447A patent/BE883087A/fr not_active IP Right Cessation
- 1980-05-02 NO NO801296A patent/NO153572C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT369365B (de) | 1982-12-27 |
| IL59681A0 (en) | 1980-06-30 |
| AU5707780A (en) | 1980-11-06 |
| CA1148963A (en) | 1983-06-28 |
| ATA232780A (de) | 1982-05-15 |
| SE434745B (sv) | 1984-08-13 |
| IE49564B1 (en) | 1985-10-30 |
| DE3014738A1 (de) | 1980-11-13 |
| PH15963A (en) | 1983-05-04 |
| NO801296L (no) | 1980-11-05 |
| FR2455598A1 (fr) | 1980-11-28 |
| DK154503B (da) | 1988-11-21 |
| DK193580A (da) | 1980-11-05 |
| IT1127441B (it) | 1986-05-21 |
| AU531739B2 (en) | 1983-09-01 |
| US4206125A (en) | 1980-06-03 |
| NZ193236A (en) | 1982-09-14 |
| NO153572C (no) | 1986-04-16 |
| BE883087A (fr) | 1980-09-01 |
| JPS642115B2 (en:Method) | 1989-01-13 |
| DE3014738C2 (en:Method) | 1989-08-03 |
| SE8003243L (sv) | 1980-11-05 |
| IE800572L (en) | 1980-11-04 |
| NL8002208A (nl) | 1980-11-06 |
| NO153572B (no) | 1986-01-06 |
| JPS55147274A (en) | 1980-11-17 |
| ES490814A0 (es) | 1981-05-16 |
| IL59681A (en) | 1984-04-30 |
| CH645372A5 (de) | 1984-09-28 |
| FR2455598B1 (en:Method) | 1983-05-27 |
| GB2051780B (en) | 1982-12-22 |
| ZA801603B (en) | 1981-03-25 |
| ES8104997A1 (es) | 1981-05-16 |
| IT8048373A0 (it) | 1980-04-09 |
| GB2051780A (en) | 1981-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK151884C (da) | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK462380A (da) | Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf | |
| DK160940C (da) | Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf | |
| DK155048C (da) | Analogifremgangsmaade til fremstilling af 1,8-naphthyridinforbindelser | |
| DK162714C (da) | Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf | |
| DK148477C (da) | Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf | |
| DK160092C (da) | Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolin eller ikke-toxiske syreadditionssalte deraf | |
| DK151017C (da) | Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf | |
| DK134580A (da) | Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf | |
| DK142544C (da) | Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf | |
| DK146066C (da) | Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf | |
| DK157451C (da) | Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK430379A (da) | Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf | |
| DK533881A (da) | Fremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxidazol-2-oxider eller farmekologisk acceptable syreadditionsforbindelser | |
| DK154503C (da) | Analogifremgangsmaade til fremstilling af 5-(2-((2,3-dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-forbindelser eller syreadditionssalte deraf | |
| DK152427C (da) | Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK158227C (da) | Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf | |
| DK160874C (da) | Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK152754C (da) | Analogifremgangsmaade til fremstilling af 1-acyl-8-(3-amino-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinoliner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148036C (da) | Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf | |
| DK455980A (da) | Analogifremgangsmaade til fremstilling af spiroimidazolonforbindelser eller syreaddiionssalte deraf | |
| DK149889C (da) | Analogifremgangsmaade til fremstilling af dibenzo(d,g)(1,3,6)dioxazocinderivater eller syreadditionssalte deraf | |
| DK422879A (da) | Fremgangsmaade til fremstilling af n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl-benzamid eller derivater deraf | |
| DK516480A (da) | Fremgangsmaade til fremstilling af 2-amino-ethanol-derivater eller syreadditionssalte deraf | |
| DK144780A (da) | Analogifremgangsmaade til fremstilling af spiroquinolon-hydantoin-forbindelser eller syreadditionssalte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |